Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Overview of Surgery Partners Inc
Surgery Partners Inc (SGRY) is an established healthcare services company that has carved a niche in the industry through its differentiated integrated outpatient delivery model. The company brings together state-of-the-art surgical facility services and a comprehensive suite of ancillary healthcare offerings to provide quality, cost-effective care. With a focus on optimizing patient and physician experiences, the organization consistently delivers exceptional healthcare solutions tailored to the needs of diverse local markets.
Integrated Business Model
The foundation of Surgery Partners Inc is its dual-segment operational model. The Surgical Facility Services segment is the cornerstone of its revenue generation, operating a network of ambulatory surgery centers, surgical hospitals, and specialty surgery centers that enable efficient and high-quality surgical procedures. Complementing this are the Ancillary Services, which include diagnostic laboratories, multi-specialty physician practices, urgent care facilities, anesthesia services, optical centers, and specialty pharmacy services. This comprehensive suite of services forms an integrated ecosystem that improves care coordination, enhances clinical quality, and streamlines the overall patient journey.
Operational Excellence and Strategic Flexibility
Surgery Partners Inc is recognized for its operational execution and its ability to tailor its services to local market dynamics. The integration of surgical facility services with ancillary support not only differentiates the company from competitors but also allows for a level of flexibility that is critical in the evolving healthcare landscape. This approach ensures that every facility can respond to unique geographic, demographic, and clinical demands; thereby fostering high levels of patient satisfaction and physician collaboration.
Market Position and Competitive Landscape
Operating in a competitive market that encompasses both surgical and ancillary healthcare services, Surgery Partners Inc maintains a balanced presence across multiple healthcare segments. Its comprehensive service model acts as a moat by mitigating the challenges typically faced in the sector, such as high capital costs and regulatory complexities. By diversifying its offerings, the company not only reduces dependency on a single revenue source but also positions itself as a reliable partner for health systems, physicians, and patients seeking integrated care solutions.
Service Differentiation and Industry Expertise
What sets Surgery Partners Inc apart is its commitment to an integrated care model that aligns clinical operations and support services. The company's strategy involves carefully planned market entries—whether introducing a surgical facility, establishing ancillary services, or forming joint ventures with local health systems—to create a cohesive healthcare experience. This methodical approach is underpinned by extensive industry expertise, strong operational infrastructures, and a focus on quality care delivery, all of which contribute to the company’s reputation as a thoughtful, data-driven, and efficient operator in the surgical services sector.
Core Values and Strategic Business Approach
Central to the company’s philosophy is the drive to enhance communication between providers and patients. Surgery Partners Inc emphasizes a culture of collaboration, where clinical quality and operational efficiency coexist harmoniously. The company leverages its ancillary services to support surgical facilities, thereby enabling faster diagnostics, comprehensive patient monitoring, and improved overall outcomes. Such integration showcases both clinical and operational expertise and builds long-term trust with stakeholders.
Infrastructure and Service Spectrum
The company's robust network spans a wide range of healthcare service locations. By maintaining a diverse portfolio of healthcare facilities, Surgery Partners Inc is able to implement a granular market approach. This adaptability ensures that surgical and ancillary services are aligned with the distinct needs of each community, while simultaneously sustaining standardized quality metrics across the network.
Investment Research and Sector Insights
Investors and researchers examining the healthcare sector will find the operational model of Surgery Partners Inc particularly noteworthy. Its integrated approach that combines surgical operations with critical ancillary services provides a blueprint for effective healthcare delivery. The company’s capacity to integrate various aspects of patient care within a single operational framework not only streamlines efficiency but also mitigates potential risks inherent in a segmented service structure.
Conclusion
In summary, Surgery Partners Inc offers a comprehensive, integrated model in the healthcare services arena. Its focus on merging surgical facility services with a spectrum of ancillary support has allowed it to develop a competitive advantage in a multifaceted industry. For stakeholders ranging from patients to physicians and financial analysts, the company represents a paradigm of operational excellence, strategic flexibility, and unwavering dedication to enhancing patient care. This detailed overview provides a deep dive into a business model where quality, efficiency, and integrated service delivery converge, reflecting both the complexity and the thoughtful design of its operational blueprint.
Surgery Partners (NASDAQ:SGRY) reported strong financial results for Q4 and full year 2024. Revenue increased 17.5% to $864.4M in Q4 and 13.5% to $3.1B for the full year. Same-facility revenues grew 5.6% in Q4 and 8.0% for 2024.
The company posted Q4 Adjusted EBITDA of $163.8M, up 15.1%, and full-year Adjusted EBITDA of $508.2M, a 16.0% increase. However, net losses were $108.5M for Q4 and $168.1M for 2024.
For 2025, Surgery Partners projects revenue between $3.30B-$3.45B and Adjusted EBITDA of $555M-$565M. The company maintains strong liquidity with $269.5M cash and $501.5M in credit facility availability. Operating cash flows improved to $111.4M in Q4 2024 from $62.6M in Q4 2023.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its fourth quarter 2024 earnings release for Monday, March 3, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time on the same day.
Participants can access the call via phone using 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks until March 17, 2025, accessible at 1-844-512-2921 (domestic) or 1-412-317-6671 (international) using passcode 13751533. A simultaneous webcast will be available on the Investor Relations section of the company's website.
Surgery Partners (NASDAQ: SGRY) has received a non-binding acquisition proposal from Bain Capital Private Equity to purchase all outstanding shares not already owned by Bain Capital for $25.75 per share in cash. Bain Capital and its affiliates currently own approximately 39% of the Company's outstanding common stock.
A Special Committee of independent directors will evaluate the proposal with independent financial and legal advisors. The proposed transaction would require approval from both a majority of non-Bain Capital shareholders and a Special Committee of independent directors.
The company emphasizes that no decisions have been made regarding the proposal, and there is no guarantee that a definitive offer will be made or that any transaction will be completed.
Surgery Partners (NASDAQ:SGRY) has appointed Dr. Laura L. Forese as an independent director to its Board of Directors, effective January 10, 2025, expanding the board to eleven members. Dr. Forese brings over 40 years of healthcare experience, most recently serving as executive vice president and chief operating officer at New York-Presbyterian, overseeing 10 hospital campuses, 200 medical facilities, and 45,000+ employees.
As an orthopedic surgeon with extensive healthcare administration experience, Dr. Forese previously established the New York-Presbyterian Medical Groups, focusing on standardizing practices and expanding regional presence. She holds leadership positions in various healthcare organizations, including chair emerita of the NIH Clinical Research Hospital board and serves on multiple corporate boards. Dr. Forese earned her medical degree from Columbia University and a masters in health services management, along with a bachelor's in civil engineering from Princeton University.
Surgery Partners (NASDAQ:SGRY) reported strong Q3 2024 results with revenues increasing 14.3% to $770.4 million. Same-facility revenues grew 4.2% with a 3.7% increase in cases. The company posted a net loss of $31.7 million, while Adjusted EBITDA rose 21.9% to $128.6 million with a margin expansion of 100 basis points to 16.7%. The company maintains strong liquidity with $221.8 million in cash and $595.8 million in revolving credit facility capacity. Operating cash flow was $65.2 million for Q3. Surgery Partners reaffirmed its 2024 guidance, expecting revenues over $3.075 billion and Adjusted EBITDA exceeding $508 million.
Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, has announced the release date for its third quarter 2024 financial results. The company will disclose its earnings before the market opens on Tuesday, November 12, 2024, followed by a conference call at 8:30 a.m. Eastern Time.
Investors and interested parties can access the live call by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks after the call. Additionally, a simultaneous webcast of the conference call will be accessible through the Investor Relations section of the company's website at www.surgerypartners.com.
Surgery Partners, Inc. (NASDAQ:SGRY) reported strong Q2 2024 results, raising full-year guidance. Key highlights include:
- Revenues increased 14.2% to $762.1 million
- Same-facility revenues up 9.9%
- Adjusted EBITDA grew 18.1% to $118.3 million
- Adjusted EBITDA margin expanded 50 basis points to 15.5%
- Full-year guidance raised to >$3.075 billion revenue and >$508 million Adjusted EBITDA
The company deployed nearly $220 million on acquisitions and improved its balance sheet position. Cash and cash equivalents stood at $213.5 million, with $647.8 million available under its revolving credit facility. The total net debt to EBITDA ratio was approximately 3.8x at quarter-end.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has announced the release date for its second quarter 2024 earnings report. The company will disclose its financial results before the market opens on Tuesday, August 6, 2024, followed by a conference call at 8:30 a.m. Eastern Time.
Investors can access the live call by dialing 1-800-579-2543 (domestic) or 1-785-424-1789 (international) with the Conference ID: SPI2Q24. A replay will be available for two weeks after the call. Additionally, a simultaneous webcast will be accessible through the Investor Relations section of the company's website at www.surgerypartners.com.
Surgery Partners, Inc. reported strong financial results for the first quarter of 2024, with revenues increasing by 7.7% to $717.4 million. The company's same-facility revenues grew by 10.2%, while the net loss was $12.4 million. Adjusted EBITDA reached $97.5 million, with an 8.2% growth compared to the previous year. The company raised its full-year 2024 guidance to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA. Surgery Partners' executives highlighted strong growth driven by clinical quality, operational execution, and strategic acquisitions.
FAQ
What is the current stock price of Surgery Partners (SGRY)?
What is the market cap of Surgery Partners (SGRY)?
What is the primary focus of Surgery Partners Inc?
How does Surgery Partners Inc differentiate itself in the healthcare market?
Which segments comprise the business model of Surgery Partners Inc?
What benefits does the integrated outpatient delivery model offer?
How does the company tailor its services to different local markets?
What types of ancillary services does Surgery Partners Inc offer?
How is the company positioned in the competitive landscape of healthcare services?
What key industry trends support the integrated model used by Surgery Partners Inc?
How does the integration of surgical and ancillary services impact patient care?
